The burden of hospitalizations for anus and penis neoplasm in Spain (1997-2008)

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 2, 2012, Pages 201-207

  Gil Prieto, Ruth ^a   Ester, Pablo Viguera ^a   Álvaro Meca, Alejandro ^a   Rodríguez, María San Martín ^b   De Miguel, Ángel Gil ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Sanofi Pasteur MSD   (Spain)

Author keywords

Anus; Hospitalizations; HPV; Malign neoplasm; Penis; Spain

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANUS TUMOR; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE CONTROL; FATALITY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAPILLOMAVIRUS INFECTION; PENIS TUMOR; PRESCHOOL CHILD; PREVALENCE; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SMOKING HABIT; SPAIN; VACCINATION; VIRUS DETECTION; AGE; ANUS CANCER; CANCER MORTALITY; HOSPITAL COST; PENIS CANCER; SMOKING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PENILE NEOPLASMS; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 84861831740     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.18388     Document Type: Article

References (38)

1. Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46(Suppl):S20-6; PMID:20307840; http://dx.doi.org/10.1016/j.jadohealth.2010.01.016
2. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24(suppl 3):S3/11-25; PMID:16949997; http://dx.doi.org/10.1016/j.vaccine. 2006.05.111
3. Baudet JS, Castro V, Díaz-Bethencourt D, Morales S, Avilés J. Papilomatosis bowenoide. [Bowenoide papulosis. An anal intraepithelial neoplasia]. Rev Esp Enferm Dig 2009; 101:440-1; PMID:19630470
4. Santos Arrontes D, Páez Borda A, Luján Galán M, Llanes González L, Escalera Almendros C, Pascual Mateos C, et al. Incidencia del cáncer urológico en un área sanitaria de 300.000 habitantes. Actas Urol Esp [Internet]. 2004 10 Available at URL: http://scielo.isciii.es/scielo.php? pid=S0210-48062004000900003&script=sci- arttext [last consulted 8/11/2010]
5. Di Capua Sacoto C, Lujan Marco S, Morales Solchaga G, Budía Alba A, Pontones Moreno JL, Jiménez Cruz JF. Cancer of the penis. Our experience in 15 years. Actas Urol Esp 2009; 33:143-8; PMID:19418837
6. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. The Prevalence of Genital HPV and Factors Associated With Oncogenic HPV Among Men Having Sex With Men and Men Having Sex With Women and Men: The HIM Study. Sex Transm Dis 2011; 38:932-40; PMID:21934568; http://dx.doi.org/10.1097/ OLQ.0b013e31822154f9
7. McIntyre M, Weiss A, Wahlquist A, Keane T, Clarke H, Savage S. Penile cancer: an analysis of socioeconomic factors at a southeastern tertiary referral center. Can J Urol 2011; 18:5524-8; PMID:21333043
8. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-8; PMID:9358129; http://dx.doi.org/10. 1056/NEJM199711063371904
9. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006 Ago 31;24 Suppl 3: S3/11-25.
10. Spence AR, Franco EL, Ferenczy A. The Role of Human Papillomaviruses in Cancer. Evidence to Date. Am J Cancer 2005; 4:49-64; http://dx.doi.org/10.2165/ 00024669-200504010-00004
11. StatBite. Proportion of specific cancers caused by HPV. J Natl Cancer Inst 2010; 102:839 . Epub Ahead of Print. PMID:20530763; http://dx.doi.org/10. 1093/jnci/djq224
12. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989; 49:4677-81; PMID:2547512
13. Nyitray AG, Smith D, Villa L, Lazcano-Ponce E, Abrahamsen M, Papenfuss M, et al. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis 2010; 201:1498-508; PMID:20367457; http://dx.doi.org/10.1086/652187
14. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011; 203:49-57; PMID:21148496; http://dx.doi.org/10.1093/infdis/jiq021
15. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepitelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2008; 124:1626-36; http://dx.doi.org/10.1002/ijc.24116
16. Gil A, San-Martín M, Gil R, Hernández V, Ribes J, González A. Burden of hospital admissions for cervical cancer in Spain during 1999-2002. Hum Vaccin 2007; 3:276-80; PMID:17938579
17. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, et al. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 2009; 130:222-33; PMID:19901431
18. Camarelles Guillem F. Policies of prevention and monitoring of tobacco dependency. Aten Primaria 2005; 35:387-9; PMID:15882492
19. Goldman S, Glimelius B, Nilsson B, Påhlman L. Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir Scand 1989; 155:191-7; PMID: 2741627
20. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-8; PMID: 15241824; http://dx.doi.org/10.1002/cncr.20364
21. Frisch M, Melbye M, Møller H. Trends in incidence of anal cancer in Denmark. BMJ 1993; 306:419-22; PMID:8461721; http://dx.doi.org/10.1136/bmj. 306.6875.419
22. Ortholan C, François E, Gérard J. Preneoplastic anal lesions and anal canal carcinoma. Bull Cancer 2003; 90:405-11; PMID:12850763
23. Robinson D, Coupland V, Møller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 2009; 100:527-531; PMID: 19156144; http://dx.doi.org/10.1038/sj.bjc.6604871
24. Smith MA, Canfell K, Brotherton JML, Lew J, Barnabas RV. The predicted impact of vaccination on human papillomavirus infections in Australia. Int J Cancer 2008; 123:1854-63; PMID:18636563; http://dx.doi.org/10.1002/ijc.23633
25. Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefano B. De
26. Sánchez MJ, Payer T, De Angelis R, Larrañaga N, Capocaccia R, Martinez C & CIBERESP Working Group. Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012. Ann Oncol 2010; 21(Suppl 3):iii30-6; PMID: 20427358; http://dx.doi.org/10.1093/annonc/mdq090
27. D'Hauwers KW, Tjalma WA. HPV in men. Eur J Gynaecol Oncol 2008; 29:338-40; PMID:18714565
28. Kreuter A, Wieland U. Human papillomavirusassociated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009; 22:109-14; PMID:19276878; http://dx.doi.org/10.1097/QCO.0b013e3283229fc8
29. Jin F, Stein AN, Conway EL, Regan DG, Law M, Brotherton JM, et al. Trends in anal cancer in Australia, 1982-2005. Vaccine 2011; 29:2322-7; PMID:21255682; http://dx.doi.org/10.1016/j.vaccine.2011.01.015
30. Peiró S, Librero J. Evaluación de la calidad a partir del conjunto mínimo de datos básicos al alta hospitalaria. Rev Neurol 1999; 29:651-61; PMID:10599116
31. Ministerio de sanidad y Consumo. Análisis y desarrollo de los GDR en el Sistema Nacional de Salud. available in URL: www.msc.es/estadEstudios/ estadisticas/docs/ analisis.pdf. Consulted on 10/06/2010.
32. Smith MA, Lew JB, Walker RJ, Brotherton JM, Nickson C, Canfell K. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine 2011; 29:9112-22; PMID:21419773; http://dx.doi.org/10.1016/j.vaccine.2011.02.091
33. Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Cancer 2008; 113(Suppl):2936-45; PMID:18980277; http://dx.doi.org/10.1002/cncr.23761
34. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008; 198:500.e1-7; PMID:18455524; http://dx.doi.org/10.1016/j.ajog.2008.03.064
35. Ministerio de Sanidad y Consumo. Clasificación internacional de enfermedades 9 revisión, modificación clínica. 1996: 375-6. Available in URL: http://www.msc.es/estadEstudios/estadisticas/normalizacion/ clasifEnferm/ instrucNorma.htm Consulted on 10/06/2010.
36. Instituto Nacional de la Salud. Subdirección General de Coordinación Administrativa. Conjunto Mínimo Básico de Datos. Hospitales del INSALUD2001. Madrid 2002. Available in URL: http://www.ingesa. msc.es/. Consulted on 10/06/2010.
37. Rivero Cuadrado A. El conjunto mínimo básico de datos en el SNS: inicios y desarrollo actual. Rev Fuentes Estadísticas 2000; 49:18-19. Available in URL: http:// www.ingesa.msc.es/estadEstudios/ documPublica/pdf/ grds-2001.pdf Consulted on 10/06/2010.
38. Schreyögg J, Stargardt T, Tiemann O, Busse R. Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci 2006; 9:215-23; PMID:17016927; http://dx.doi.org/10.1007/s10729-006-9040-1